China's drug regulator said on Friday that it has given the nod for a brain-computer interface (BCI) system that helps restore hand-movement ability to be sold, the world's first approval of a BCI device for commercial use. The device is made by Borui Kang Medical Technology (Shanghai) and its tech aims to restore movement and communication to humans suffering from different forms of paralysis. ADVERTISEMENTIt is designed for patients with quadriplegia caused by cervical spinal cord injuries, helping them regain hand-grasping ability via a glove. The product is an invasive BCI system, which means electrodes are inserted directly into the brain, instead of sitting on the surface of the brain. The National Medical Products Administration said BCI products like the one approved on Friday have been prioritised, noting the sector has been designated a "future industry" in Beijing's latest five-year plan released last week.

Source: The Telegraph March 13, 2026 09:13 UTC